LFCR

Lifecore Biomedical Inc.

LFCR, USA

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

https://www.lifecore.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
LFCR
stock
LFCR

Understanding the Setup: (LFCR) and Scalable Risk news.stocktradersdaily.com

Read more →
LFCR
stock
LFCR

The Technical Signals Behind (LFCR) That Institutions Follow news.stocktradersdaily.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-08-31)

Rating:

BUY

Target Price:

$8.75

Analyst Picks

Strong Buy

2

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-08-31)

Health Score

Price to Book Ratio (P/B)

-

Very High

7.92

Low ≤ 1

High ≄ 3

Return on Equity (ROE)

-

Very Low

-27.16 %

Low ≤ 5%

High ≄ 25%

Return on Assets (ROA)

-

Very Low

-4.25 %

Low ≤ 2%

High ≄ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.08 %

Low ≤ 5%

High ≄ 15%

Debt to Equity

-

Very Low

5.39

Low ≄ 1

High ≤ 0.3

Investors

* Institutions hold a combined 71.16% of the total shares of Lifecore Biomedical Inc.

1.

Wynnefield Capital Inc

(12.5728%)

since

2025/06/30

2.

Legion Partners Asset Management, LLC

(11.8473%)

since

2025/06/30

4.

325 Capital LLC

(5.7808%)

since

2025/06/30

5.

BlackRock Inc

(5.0118%)

since

2025/06/30

6.

Vanguard Group Inc

(4.3037%)

since

2025/06/30

7.

Geode Capital Management, LLC

(2.0731%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(2.0614%)

since

2025/07/31

9.

Morgan Stanley - Brokerage Accounts

(1.9777%)

since

2025/06/30

10.

iShares Russell 2000 ETF

(1.7299%)

since

2025/08/31

11.

State Street Corp

(1.4196%)

since

2025/06/30

12.

DCF Advisers, LLC

(1.2377%)

since

2025/06/30

13.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0858%)

since

2025/07/31

14.

Amvescap Plc.

(1.0143%)

since

2025/06/30

15.

Invesco Dorsey Wright SmallCap Momt ETF

(0.9557%)

since

2025/08/29

16.

Fidelity Small Cap Index

(0.7301%)

since

2025/06/30

17.

22NW, LP

(0.7062%)

since

2025/06/30

18.

Northern Trust Corp

(0.6507%)

since

2025/06/30

19.

Quinn Opportunity Partners LLC

(0.5407%)

since

2025/06/30

20.

Fidelity Extended Market Index

(0.5329%)

since

2025/07/31

21.

iShares Russell 2000 Growth ETF

(0.494%)

since

2025/08/31

22.

Tocqueville Asset Management L.P.

(0.4055%)

since

2025/06/30

23.

LPL Financial Corp

(0.3961%)

since

2025/06/30

24.

LANDSCAPE CAPITAL MANAGEMENT,LLC

(0.3647%)

since

2025/06/30

25.

Vanguard Russell 2000 ETF

(0.351%)

since

2025/07/31

26.

Royal Bank of Canada

(0.3324%)

since

2025/06/30

27.

UBS Group AG

(0.2584%)

since

2025/06/30

28.

State St Russell Sm CapĀ® Indx SL Cl I

(0.2425%)

since

2025/08/31

29.

Delafield Concentrated Value

(0.2406%)

since

2025/06/30

30.

Charles Schwab Investment Management Inc

(0.2344%)

since

2025/06/30

31.

1290 VT GAMCO Small Company Value IB

(0.2098%)

since

2025/07/31

32.

Extended Equity Market Fund K

(0.1905%)

since

2025/06/30

33.

Fidelity Total Market Index

(0.1886%)

since

2025/07/31

34.

Schwab Small Cap Index

(0.1851%)

since

2025/07/31

35.

iShares Russell 2000 Value ETF

(0.1785%)

since

2025/08/31

36.

NT R2000 Index Fund - NL

(0.1784%)

since

2025/06/30

37.

iShares Micro-Cap ETF

(0.1669%)

since

2025/08/31

38.

Bridgeway Ultra-Small Company Market

(0.1521%)

since

2025/06/30

39.

NT R2000 Index Fund - DC - NL - 3

(0.1422%)

since

2025/06/30

40.

Fidelity Series Total Market Index

(0.1392%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-11-30

EPS Estimate

-0.165

Latest Release

Date

2025-08-31

EPS Actual

-0.29

EPS Estimate

-0.305

EPS Difference

0.015

Surprise Percent

4.918%

Investing Fit Scorecard

(Last Updated 2025-08-31)

Deep Value
Potential Value Candidate(3.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(2.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(3)
Value
Overpriced(2)

Income Statement

(Last Updated 2025-08-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-08-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-08-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.